amanda
First-in-human implant of BeGrow stent performed in 24-day old baby
A 24-day old infant has received the first-in-human placement of BeGrow (Bentley), a novel stent s...
FDA approves RADIANCE-II study of Paradise ultrasound denervation system
The RADIANCE-II study of the Paradise Ultrasound Denervation System (ReCor Medical) for the trea...
PERT Consortium and BTG form strategic partnership
BTG has announced a strategic partnership with the PERT Consortium to advance the science of pul...
Europe braces for harder times in medical device innovation while US FDA eases regulations
Countries in the European Union have long been the first to receive new innovations in medical techn...
Edwards PCR London Valves TNT symposium summary: reviewing the impact from 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
In this video, hear how key recommendations from the 2017 ESC/EACTS Guidelines for the Management of...
Cardiovascular News Issue 47 – November 2017 US edition
Highlights:
SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers bloo...
Cardiovascular News Issue 47 – November 2017
Highlights:
SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers bloo...
Delayed diagnosis affects women’s treatment for heart disease
Factors such as delayed diagnosis may contribute to the differences in women and men’s treatment for...
BioCardia phase III CardiAMP trial passes interim safety analysis
The independent Data Safety Monitoring Board (DSMB) has found no significant safety concerns wit...
Medtronic HeartWare HVAD approved for destination therapy
The US Food and Drug Administration (FDA) has approved Medtronic’s HeartWare HVAD system as a de...
US FDA accepts PMA application for TherOx’ SSO2
The US Food and Drug Administration (FDA) has accepted TherOx’ Premarket Approval (PMA) application ...
US FDA approves coronary indication for ReFlow’s Wingman
ReFlow Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to marke...
FDA issues class I recall for Spectranetics’ Bridge occlusion balloon catheter
Spectranetics has recalled the Bridge occlusion catheter “due to the possibility of a blocked gu...
New performance and quality measures for treating heart attack patients
The American College of Cardiology (ACC) and the American Heart Association (AHA) have released upda...
Creavo’s Vitalscan “rule out” technology on show at EUSEM
A new scanning device designed to aid cardiac ‘rule out’ is to be exhibited at the EUSEM Europea...
Re-interventions common in long-term Fontan procedure survivors
Among patients who undergo the Fontan procedure, two-thirds of survivors require a surgical or c...
Average age and income of US cardiologists on the rise
According to a new survey, the average age and income of cardiologists in the US are increasing.
...
US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device
BioStable Science & Engineering has received US Food and Drug Administration (FDA) market cl...
“Singheart” offers step towards heart regeneration
New research has discovered a potential means to trigger damaged heart cells to self-heal. For t...
Heart failure patient and clinician risk perceptions differ drastically
Physicians identified a majority of patients with advanced heart failure as at high risk for transpl...
Medtronic to undertake global randomised clinical trial of one-month DAPT in Resolute Onyx patients
Medtronic has announced a global randomised clinical trial that will evaluate one-month dual ant...
HeartFlow FFRct Analysis receives four Blue Cross Shield endorsements
Four Blue Cross Shield companies have issued positive medical policies for the HeartFlows FFRct ...
Marijuana use associated with three-fold risk of death from hypertension
Marijuana use is associated with a three-fold risk of death from hypertension, according to research...
LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on payment
LivaNova’s Perceval sutureless aortic heart valve has received approval from the US Centers for ...
Social inequality may impact adult cardiovascular risk before birth
Children from socially and economically disadvantaged families and neighborhoods appear more likely ...
French doctors revise emergency plans to better deal with terrorism
In a Viewpoint published in The Lancet, Pierre Carli (University Paris-Descartes, Paris, France;...
New PET-CT scan improves detection of sarcoidosis secondary to cardiac
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than tradit...
Millipede 50mm annuloplasty ring used in first cases
Millipede has announced the successful implantation of its newest 50mm Iris annuloplasty ring, w...
European Medicines Agency issues positive opinion for rivaroxaban
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment
4C Medical has received approximately US$9 million in unsecured convertible promissory notes. The co...
Some plant-based diets associated with higher risk of heart disease
Plant-based diets are recommended to reduce the risk of heart disease; however, some plant-based die...
Cardiovascular drugs behind almost a quarter of medication error-related serious medical outcomes
Every 21 seconds someone in the USA calls Poison Control because of a medication error. A new study ...
Meta-Analysis compares the safety and efficacy of S-DAPT and L-DAPT at two years
Researchers have evaluated the long-term efficacy and safety of long duration dual anti-platelet the...
GE Healthcare and HeartFlow announce global collaboration
GE Healthcare and HeartFlow have entered into a global collaboration agreement with the goal of ...
Sildenafil-coated stent may help prevent blood clots and restenosis
A stent coated with sildenafil (Viagra, Pfizer, and others) may someday help prevent arteries fr...
Radical changes required to ensure US women receive optimal healthcare
Radical changes to our health care system that take into account the unique needs of women, includin...
Medtronic releases Resolute Onyx drug-eluting stent in Japan
Medtronic will release the Resolute Onyx coronary stent system in Japan. According to a press re...
AMA issues unique Category III Current Procedural Terminology codes for HeartFlow FFRct
The American Medical Association (AMA) has issued a set of new Category III Current Procedural T...
First German order for Acarix’ CADScore system
A private cardiology clinic in Berlin, Germany, headed by Niels Jacobsohn has placed the first o...
Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates
Researchers at Georgia Institute of Technology and the Piedmont Heart Institute (both Atlanta, USA) ...
Shingles associated with stroke and heart attack
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of strok...
Europace 2017: Breast implants may lead to false heart attack diagnosis
Breast implants may disrupt an electrocardiogram (ECG) and could result in a false heart attack ...
Obamacare health insurance expansion linked to fewer cardiac arrests
A sudden catastrophic loss of heart function, or cardiac arrest, occurred significantly less among a...
Childhood asthma may lead to thickening of left ventricle in adulthood
Young adults with a history of asthma are at a greater risk of thickening of the left ventricle acco...
Teleflex’s Vascular Solutions issues recall of Venture catheters
A worldwide recall of Venture catheters has been voluntarily initiated by its Teleflex’s Vascular So...
Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors
Novartis has announced topline results from the global Phase III CANTOS study investigating the effi...
Nearly half of US women unaware that heart disease is their primary killer
Women and their physicians are largely uneducated when it comes to females and heart disease, puttin...
Negative late lumen loss at 24 months for TriReme Chocolate Heart
TriReme Medical, a subsidiary of QT Vascular, has announced that its angiographic data from a 24...
Italian boy becomes youngest patient bridged to transplant with the SynCardia Total Artificial Heart
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s you...
UK public health groups launch “Everyday Interactions” toolkit to measure professionals’ public health impact
Public Health England (PHE) and the Royal Society for Public Health (RSPH) have published “Everyday ...
US FDA grants clearance to FlowGlide technology from ClearFlow
The United States Food & Drug Administration (FDA) has granted 510(k) clearance for ClearFlow’s ...
German court awards Edwards Lifesciences co-entitlement of Neovasc’s Tiara patent application
The District Court in Munich, Germany has partially found in favour of Edwards Lifesciences Corp...
Sapien 3 receives expanded FDA indication for valve-in-valve procedures
Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for aortic and ...
First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place
The first ever Inspiris Resilia aortic valve (Edwards Lifesciences) implantation procedures have...
Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched
Philips has announced the relaunch of the Pioneer Plus catheter, described as the only re-entry ...
EuroPCR 2017: Micell Technologies’ MiStent non-inferior to Abbot Xience in all-comers RCT
Micell Technologies has announced positive twelve-month data from its DESSOLVE III clinical tria...
Michael Buck named HeartFlow executive vice president and chief commercial officer
HeartFlow has announced the appointment of Michael Buck as executive vice president and chief co...
Ultra-sensitive cardiac troponin test using Single Molecule Counting technology receives CE mark
Singulex has been granted CE mark for its ultra-sensitive troponin assay (cTnl), the first offered b...
US FDA clears Stroke2prevent’s A-View balloon catheter
The US Food and Drug Administration (FDA) has cleared Stroke2prevent’s A-view device for commerciali...
Statins associated with improved heart structure and function
Statins are associated with improved heart structure and function, according to research presented a...
Halting methamphetamine abuse can reverse related heart damage
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve hea...
Diesel pollution linked to structural and functional heart damage
Diesel pollution is linked with heart damage, according to research presented at the annual Cardiova...
First Revivent TC ventricular enhancement procedure for ischaemic cardiomyopathy performed
BioVentrix has announced the first clinical use of its closed-chest Revivent TC transcatheter ve...
Transendocardial delivery results in greater myocardial stem cell therapy retention
According to a study published in the International Heart Journal, delivery of stem cell therapy...
EuroPCR 2017: Excellent clinical outcomes for Medtronic’s CoreValve and Evolut systems in routine practice
New positive data on the self-expanding Medtronic CoreValve platform from the CoreValve ADVANCE ...
Sponsored: Patients have to trust that if I were in their shoes, I wouldn’t do anything differently
Drug-eluting stent technology with durable polymer has shown encouraging efficacy compar...
Abiomed introduces third generation Impella CP heart pumps at SCAI 2017
Abiomed has announced the debut of the third generation Impella CP heart pump at the Annual meet...
Boston Scientific to present REPRISE III and EWOLUTION data at EuroPCR
Boston Scientific has announced the schedule of key data presentations, including four late-brea...
Large nuclear cardiology laboratory slashes radiation dose by 60% in eight years
A large nuclear cardiology laboratory has slashed its average radiation dose by 60% in eight years, ...
FDA approves Medtronic’s Resolute Onyx drug-eluting stent
The FDA has approved Medtronic’s Resolute Onyx drug-eluting stent, which the company has now lau...
Non-O blood groups associated with higher risk of heart attack
Having a non-O blood group is associated with a higher risk of heart attack, according to research p...
US FDA designates Medtronic HVAD system controller field action as class I recall
The US Food and Drug Administration (FDA) has classified Medtronic’s recently initiated voluntar...
First patient enrolled in new study of abbreviated DAPT post-stent in high bleeding risk patients
Gillian Jessurun (Treant Zorggroep, Scheper Hospital Emmen, The Netherlands) has enrolled the first ...
Cordis granted CE mark for Railway sheathless access system
Cordis has received the CE mark for its new Railway sheathless access system, which is now avail...
LATERAL study offers positive overall results for Medtronic HVAD
Preliminary results from the Medtronic -sponsored HVAD LATERAL study have demonstrated overall p...
Microport TARGET AC three-month sub-study results to be presented at EuroPCR
Results of the TARGET All Comer (AC) clinical trial will be released at annual meeting of the Euro...
Occlutech obtains CE mark for its Perimembranous ventricular septal defect occluder
Occlutech has obtained CE mark approval for its Perimembranous ventricular septal defect (PmVSD) occ...
Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint
Medtronic’s ENDURANCE Supplemental trial of the company’s HVAD ventricular assist device has fai...
First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study
HLT has announced that the first patient implants in a feasibility clinical study to assess the safe...
CE mark granted to NVT for Allegra transcatheter aortic valve
NVT has received the CE mark for its Allegra transcatheter aortic valve, which it describes as “...
Reva receives CE mark for Fantom drug-eluting scaffold
Reva has been granted CE mark approval for its Fantom drug-eluting bioresorbable coronary scaffo...
Insomnia associated with increased risk of heart attack and stroke
Insomnia is associated with increased risk of heart attack and stroke, according to new research pub...
Armetheon to merge with Espero Pharmaceuticals
Espero Pharmaceuticals and Armetheon are to merge to form a new company. Upon completion of the merg...
Boston Scientific agrees to acquire Symetis
Boston Scientific Corporation have definitively agreed to acquire Symetis, a privately-held Swiss st...
SynCardia to honour eight total artificial heart hospitals during ISHLT
This year’s SynCardia awards recognise leadership in the Destination Therapy clinical ...
Magnesium 1,000 programme reveals high deployment success for Biotronik’s Magmaris scaffold
Biotronik has released details of the clinical performance of its Magmaris magnesium scaffold in...
Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial
Cardiovascular Systems and the Cardiovascular Research Foundation (CRF) have announced that the ...
iVascular Capturer 7F granted CE mark
iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F.
The company ...
First US commercial case performed using Tryton Side branch stent
Tryton Medical has announced that the first US commercial case using the Tryton Side branch sten...
ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures
A new meta-analysis presented this week at the American College of Cardiology 66th Scientific Se...
Toshiba Medical’s AplioTM i900 cardiovascular ultrasound receives US FDA clearance
Cardiologists can now access the advanced ultrasound imaging technology needed for fast and conf...
Siemens Healthineers and HeartFlow to integrate CT and FFRct Analysis technology
Siemens Healthineers and HeartFlow are to collaborate on joint-solution computed tomography (CT)...
EBBINGHAUS trial shows non-inferiority of evolocumab for cognitive function in cardiovascular group
Amgen has announced detailed results from the evolocumab (Repatha) cognitive function trial (EBB...
RaySafe unveils new real-time dosimeter
Unfors RaySafe has introduced the RaySafe i3, to its suite of real-time dosimetry products, at the...
ACC 2017: Positive final results from ORION-1 phase II study of inclisiran
The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORI...
ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarte...
BIOFLOW-IV confirms non-inferiority of Biotronik’s Orsiro in Japan
The 12-month results of Biotronik’s BIOFLOW-IV multicentre clinical study have been presented at...
ACC 2017: Embol-X and CardioGard do not reduce number of brain lesions, but may affect lesion size
Two US Food and Drug Administration-cleared medical devices designed to remove potential vessel-bloc...
TAVI may benefit certain heart valve patients, update society guidelines say
New recommendations have been published by the American Heart Association and the American College o...
ACC 2017: Indigenous South American group has healthiest arteries ever studied
The Tsimane people—a forager-horticulturalist population of the Bolivian Amazon—have the lowest ...
ACC 2017: Acarix trial finds 97% negative predictive value for CADScor system coronary artery disease test
Acarix has announced the results from a new multicentre trial of its handheld CADScor system f...
ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency
Mary Norine Walsh has become president of the American College of Cardiology during the Convocat...
ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest strap
Researchers at Cleveland Clinic, Cleveland, USA, put five popular wrist-worn fitness trackers to the...
Coffee shops and cash machines ideal locations for lifesaving automated external defibrillators
Community coffee shops and cash machines might be ideal locations for public access to automated ext...
ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on heart
As the Zika virus continues to spread globally, new evidence has emerged about the virus’s poten...
ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations and cost of care
Late-breaking clinical research presented at the American College of Cardiology 66th Annual Scie...
ACC 2017: More hospitalisations & deaths for US heart failure patients in winter
Patients with heart failure in the USA are more likely to be hospitalised and more likely to die dur...
MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector
MR Solutions’ new 9.4 tesla cryogen-free preclinical scanners was demonstrated to cardiologists at t...
Clinical trial rules should protect patients and results not operational details, says ESC
Rules governing the conduct of clinical trials are failing to produce the intended benefits for pati...
UK Patents Court makes initial decision on Edwards Sapien 3 and Boston Scientific’s patents
The Patents Court in the UK has determined that one of Boston Scientific’s patents related to ou...
Illumina study completes enrolment
Alvimedica’s Illumina study has completed enrolment. The Illumina study has been designed to evaluat...
FDA grants approval to Tryton for side-branch stent
The US Food and Drug Administration (FDA) has approved Tryton Medical’s Premarket Approval (PMA)...
Screening for heart disease may lead to prevention, better treatments
According to a review published in JACC: Cardiovascular Imaging, the simple computed tomography (CT)...
Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban
The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, r...
US FDA grants 510(k) clearance to Teleflex for TrapLiner catheter
Teleflex incorporated has announced 510(k) clearance by the US Food and Drug Administration (FDA), a...
Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology
The second clinical case using Micro Interventional Devices’ proprietary MIA (minimally invasive ann...
LivaNova to delist from London Stock Exchange
LivaNova has applied for the voluntary cancellation of its standard listing of ordinary shares with ...
First patient treated with CardiAmp cell therapy for ischaemic heart failure in Phase III trial
Johns Hopkins Medicine, Baltimore, USA, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia h...
Few heart attack survivors get recommended physical activity
Only 16% of heart attack survivors get the recommended amount of physical activity in the weeks afte...
Elsevier announces the launch of Case: Cardiovascular Imaging Case Reports
Elsevier and the American Society of Echocardiography has announced the launch of Case: Cardiovascul...
Physical activity may be more important than BMI for cardiovascular disease risk
The benefits of physical activity may outweigh the impact of overweight and obesity on cardiovascula...
Corindus Vascular Robotics announces private placement for US$45 million
Corindus Vascular Robotics has entered into a Securities Purchase Agreement pursuant to which it...
Martha Goldberg Aronson joins Cardiovascular Systems board of directors
Cardiovascular Systems (CSI) has announced the addition of independent board member Martha Goldberg ...
Researchers urge physicians to discuss herbal medication use with heart disease patients
Physicians should be well-versed in the herbal medications heart disease patients may take to be abl...
Following dietary recommendations leads to modest heart health improvements
Following current dietary recommendations may lead to small improvements in overall heart health...
Increased physical activity, lower BMI may lower heart failure risk
While lifestyle patterns, including physical activity and body mass index (BMI), are associated with...
European Society of Cardiology publishes special collection on eHealth revolution
How are smartphones and computer programs transforming healthcare, especially when it comes to p...
Teleflex completes acquisition of Vascular Solutions
Teleflex Incorporated has completed its previously announced acquisition of Vascular Solutions.
...
Cardiovascular Systems Micro Crown sustains high freedom from major adverse events at one year
Cardiovascular Systems (CSI) has released one-year results from its Coronary Orbital Atherectomy Sys...
Intensive blood pressure control could prevent 100,000 deaths each year
Researchers have projected that aggressively lowering blood pressure could help prevent more than 10...
SentreHEART Lariat and Eclipse receive reimbursement renewal in Germany
The German Institute for the Hospital Remuneration System (InEK) has renewed Status 1—the highes...
Symetis acquires Middle Peak Medical
Symetis, a medical technology company specialising in the development, manufacturing and marketing o...
Medtronic launches Impact education and development programme in Europe, Middle East & Africa
Medtronic has announced the launch of Medtronic Impact in the Europe, Middle East & Africa regio...
NICE recommends HeartFlow FFRct Analysis to aid the determination of stable chest pain cause
The UK’s National Institute for Health and Care Excellence (NICE) has issued guidance today for use ...
Plethysmography test predicts risk for cardiovascular disease
A new test that predicts an individual's risk for developing cardiovascular disease has been launche...
Chinese air pollution linked to respiratory and cardiovascular deaths
In the largest epidemiological study conducted in the developing world, researchers found that as ex...
Medtronic releases DxTerity diagnostic catheters and transradial approach tool
Medtronic has launched the DxTerity diagnostic angiography catheter line, and several ...
First commercial procedures performed with Corindus CorPath GRX system
The first commercial procedures using Corindus Vascular Robotics’ CorPath GRX system have been perfo...
US FDA agrees to 1000-patient pivotal trial of Armetheon’s tecarfarin
Armetheon has reached agreement with the US Food and Drug Administration (FDA) for a single 1000-pat...
COMPASS study of rivaroxaban to end early for efficacy
The phase three COMPASS trial, evaluating the efficacy and safety of rivaroxaban (Xarelto, Bayer) fo...
Cancer drug promotes regeneration of damaged heart tissue
An anticancer agent in development has been shown to promote regeneration of damaged heart muscl...
US FDA grants Fast Track designation to Angionetics’ Generx coronary heart disease gene therapy
The US Food and Drug Administration (FDA) has granted Angionetics “Fast Track” designation for the p...
Study demonstrates sustained benefit of endovascular intervention in patients with lower extremity peripheral artery disease
Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market s...
New guidelines released to improve stroke reporting following cardiac procedures
In response to a growing body of evidence of the existence of "covert" brain injury to patients ...
Veryan Medical receives £13.5m further funding
Veryan Medical has received a further £13.5m of funding in the form of both equity and debt from...
Evolocumab significantly reduces risk of cardiovascular events
The FOURIER trial evaluating whether evolocumab (Repatha, Amgen) reduces the risk of cardiovascu...
Edwards Lifesciences halts enrolment in Cardiaq trial
According to a SeekingAlpha transcript of an Edwards Lifesciences fourth-quarter 2016 earnings c...
Patient enrolment begins in European Somahlution DuraGraft registry
Multiple sites in Spain have begun enrolling patients in the DuraGraft coronary artery bypass grafti...
Northwestern Memorial Hospital ranked best in USA for heart attack, stroke and heart failure survival
Northwestern Memorial Hospital has been ranked best in the USA for survival of patients suffering he...
Latest statistics show heart failure on the rise
The number of adults living with heart failure increased from about 5.7 million (2009-2012) to a...
Frances Dea named new SCAI executive director
The Society for Cardiovascular Angiography and Interventions (SCAI) has named Francesca Dea, its...
Edwards Lifesciences completes acquisition of Valtech Cardio
Edwards Lifesciences has closed its previously announced acquisition of Valtech Cardio, develope...
Positive results for heart surgery in elderly aortic stenosis patients
Elderly patients with aortic stenosis and medium surgical risk experienced better than expected resu...
Next-generation troponin T test from Roche cleared by US FDA
Roche has received US Food and Drug Administration (FDA) 510(k) clearance for its Elecsys troponin T...
Alvimedica receives CE mark for amphilimus-eluting Cre8 EVO stent
Alvimedica has received the CE mark for its new polymer-free amphilimus-eluting stent, Cre8 EVO.
...
Medtronic receives CE mark for 34mm size CoreValve Evolut R
The CE mark has been granted to Medtronic for the 34mm-valve version of its CoreValve Evolut R, ...
Robert Califf to resign as US FDA commissioner
Robert Califf is to step down as US Food and Drug Administration (FDA) commissioner upon the ina...
Clínica Universidad de Navarra implants Spain’s first SynCardia Total Artificial Heart
A medical team from Clínica Universidad de Navarra in Pamplona, Spain, has successfully performe...
Researchers discover mechanism linking stress to heart disease
Heightened activity in the amygdala has been associated with a greater risk of heart disease and str...
OrbusNeich releases next-generation coronary scoring balloon
OrbusNeich has launched the Scoreflex NC, a non-compliant scoring balloon targeting more resistant l...
New AHA/ACC guidance released for TAVI
A new expert consensus decision pathway will assist clinicians and hospitals in assessing patients’ ...
Arterys receives US FDA clearance for cardio imaging analytics software
Arterys has received 510(k) clearance from the US Food and Drug Administration (FDA) to market i...
St Jude Medical announces Merlin cybersecurity updates
St Jude Medical has announced that it will immediately deploy the latest release of cyber security u...
The Medicines Company announces positive 180-day results for PCSK9 inhibitor
The Medicines Company has announced positive top-line results from the interim analysis with 180-day...
Medinol reports positive clinical results for Elunir elastomer-coated drug-eluting stent
Twelve-month clinical results from Medinol’s BIONICS study have demonstrated that the company’s Elun...
ACC releases new appropriate use criteria for coronary revascularisation
The American College of Cardiology (ACC), along with several partnering organisations, has released ...
Women fare better than men one year after transcatheter aortic valve implantation
Women with significant aortic valve disease who undergo transcatheter aortic valve implantation ...
New ACC/AHA report outlines 10 measures for the prevention of sudden cardiac death
A new report from the American College of Cardiology and the American Heart Association presents 10 ...
Micro Interventional Devices has first-in-human success with MIA technology
Micro Interventional Devices has successfully completed the first clinical implantation of its propr...
Blood troponin level could predict silent heart disease risk
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack ...
US FDA bans powdered gloves
The US Food and Drug Administration (FDA) has issued a final rule to ban powdered surgical glove...
NICE collaborates with US FDA on Payer Communication Taskforce
The UK’s National Institute for Health and Care Excellence (NICE) has announced its participatio...
Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business
Terumo has reached an agreement with Abbott and St Jude Medical to acquire certain products owned by...
Patients with acute coronary syndrome at increased risk of suicide
Patients with acute coronary syndrome may be at an increased risk for suicide compared to otherwise ...
Boston Scientific closes acquisition of certain Neovasc assets
Boston Scientific Corporation has closed its acquisition of certain manufacturing assets and cap...
AngioSoma appoints new chief executive officer
AngioSoma has appointed Ken Stephenson as chief executive officer, board member, and president of th...
4Tech appoints Michael Ennen as president and chief executive officer
4Tech has appointed Michael Ennen as president and chief executive officer, effective immediately. E...
Japan’s Ministry of Health, Labor and Welfare approves reimbursement for Medtronic’s CoreValve Evolut R system
Medtronic has been granted reimbursement approval from the Japanese Ministry of Health, Labor an...
Boston Scientific to acquire Neovasc biological tissue capabilities
Boston Scientific has agreed to acquire certain manufacturing assets and capabilities of the Neo...
Medtronic first to receive CE mark for less-invasive HVAD implant procedure
Medtronic’s HVAD system left ventricular assist device (LVAD) has received the CE mark for a les...
Toshiba receives US FDA clearances for new CT reconstruction tech and Vantage MR software
Toshiba Medical’s Forward projected model-based iterative reconstruction solution (FIRST) and Va...
Amsel Medical to present Occluder research at ICI 2016
Amsel Medical Corporation is to present initial animal results of its “A Novel Mechanical Closure De...
Complete sanitation of robotic surgical instruments virtually impossible
It is virtually impossible to remove all contamination from robotic surgical instruments, even after...
London Valves 2016: Edwards announces SAPIEN 3™ valve CE Mark approved for intermediate-risk patients
PCR London Valves 2016 opened in the main arena with the Edwards Lifesciences TNT session "TAVI ...
US FDA issues Class I recall for 8040 Leonhard Lang multifunction defibrillation electrodes
The Leonhard Lang defibrillation electrode DF29N is being recalled due to a connector compatibil...
St. Jude Medical and Abbott to sell portion of vascular closure and electrophysiology businesses to Terumo
Abbott and St. Jude Medical have announced an agreement in principle to sell certain products to...
Philips collaborates with World Heart Federation, launches health behaviours website
Royal Philips has announced a new partnership with the World Heart Federation (WHF) to help people b...
Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication
Opsens has announced 510(k) clearance from the US Food and Drug Administration (FDA) for the Opt...
Young women with premature acute coronary syndrome now do as well as men
It has become commonly accepted that women do worse than men following a heart attack or other coron...
Visceral abdominal fat associated with newly-identified heart disease risk factors
Increasing stomach fat—especially abdominal visceral fat—has been associated with newly- Framing...
Sapien 3 now approved for intermediate-risk patients in Europe as well as in the USA
Following last month’s FDA approval for the expanded indication of Sapien 3 for the treatment of...
Researchers find new carotid body-removal treatment for hypertension
A team of clinical scientists at the University of Bristol (Bristol, UK) have found a new way to...
ESC launches European standards to prevent repeat heart attacks
European standards to prevent repeat heart attacks have been published in the European Journal o...
Berlin Heals announces closure of second round funding for cardiac microcurrent system
Berlin Heals has closed a second investment round in the run-up to the first-in-man application of i...
Vivasure Medical secures €16.2 million series C financing
Vivasure Medical has announced that the company has completed a series C financing of €16.2 million....
Risk factors for congenital heart defects may lie both inside and outside the heart
In new research published in PLOS Biology, University of California, Irvine (Irvine, USA) biologists...
Medtronic ranks on Dow Jones Sustainability North America Index for ninth consecutive year
Medtronic has been recognised as one of the world's leading companies for sustainability, rankin...
St Jude Medical launches trial of Amplatzer Amulet left atrial appendage occluder
The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will ev...
Women 50% more likely than men to be given incorrect diagnosis following heart attack
Women have a 50% higher chance than men of receiving the wrong initial diagnosis following a heart a...
Synthetic heart valves could help doctors improve surgical skills
A University of British Columbia (Vancouver, Canada) invention has made it possible for doctors ...
ESC 2016: Low socioeconomic status associated with higher risk of second heart attack or stroke
Low socioeconomic status has been associated with a higher risk of a second heart attack or stro...
ESC launches paper on tackling cardiac toxicity of anticancer therapies
The European Society of Cardiology has launched a novel position paper, under the auspices of its Co...
Philips launches Intellispace Cardiovascular image and information management system
Royal Philips has launched the IntelliSpace Cardiovascular 2.1, the latest version of its next-gener...
Mediterranean diet linked to lower mortality in patients with a history of cardiovascular disease
The Mediterranean diet has been associated with a reduced risk of death in patients with a histo...
ESC and EACTS launch first collaborative atrial fibrillation guidelines
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collab...
Fewer cardiovascular drugs being studied in clinical trials
The number of cardiovascular drugs in the research pipeline has declined across all phases of develo...
Edwards Sapien 3 granted expanded indication from US FDA
Edwards Lifesciences has announced US Food and Drug Administration (FDA) approval to expand use ...
Renal denervation devices are alternatives to drug therapy, Technavio reports
Analysts from Technavio have forecast the global renal denervation market to grow at a compound annu...
CE mark granted to InSeal Medical for InClosure vascular closure device
InSeal Medical has received CE mark approval for its InClosure VCD; a large bore vascular closur...
US FDA commissioner discusses future of cardiovascular medicine
Advances in technology coupled with an increased use of social media and personal devices could ...
Corindus appoints J Aaron Grantham as chief medical officer
Corindus Vascular Robotics has announced that J Aaron Grantham, an interventional cardiologist s...
Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients
Medtronic has received CE marking for the self-expanding, recapturable and repositionable CoreValv...
Mediterranean diet without low-fat element reduces cardiovascular events
Hanna E Bloomfield (Minneapolis VA Medical Center, Minneapolis, USA) and others report in Annals...
What is required for TAVI to become the new gold standard?
Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) ha...
First patients treated with CorMatrix Cardiovascular Tyke
The first patients have been treated using CorMatrix Cardiovascular’s Tyke.
The product received ...
First patient enrolled in AtriCure FROST cryoanalgesia study
The first patient has been enrolled in the FROST study at William Beaumont Hospital, Dearborn, USA. ...
Small study finds positive results for Neovasc’s Reducer system treatment for refractory angina
Positive results of a single-centre, retrospective study using the Neovasc Reducer have been publish...
Immune system linked to lower heart attack risk, suggests study
Measuring antibody levels in the blood could be used to detect a person’s heart attack risk afte...
St Jude Medical HeartMate 3 wins CARDIOSTIM-EHRA EUROPACE 2016 Innovation Award
St Jude Medical has received an Innovation Award for its HeartMate 3 left ventricular assist sys...
Biotronik’s scaffold is now approved for use in Europe
Biotronik’s bioresorbable magnesium scaffold—Magmaris—is now CE mark approved, meaning it is now...
Cardiovascular News Issue 41 – May 2016
Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred ...
Cardiovascular News Issue 41 – May 2016 US Edition
Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred ...
Cardiovascular News Issue 40 – February 2016 US Edition
Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year;...
Cardiovascular News Issue 40 – February 2016
Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year;...
Cardiovascular News Issue 39 – October 2015
Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools ...
Cardiovascular News Issue 39 – October 2015 US edition
Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools ...
Cardiovascular News Issue 38 – August 2015
Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations ...
Cardiovascular News Issue 38 – August 2015 US Edition
Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations ...
Cardiovascular News Issue 37 – May 2015 US Edition
Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest Co...
Cardiovascular News Issue 37 – May 2015
Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest Co...
Cardiovascular News Issue 36 – February 2015
Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial...
Cardiovascular News Issue 36 – February 2015 US Edition
Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial...
Cardiovascular News Issue 35 – September 2014
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -...
Cardiovascular News Issue 35 – September 2014 US Edition
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -...
Cardiovascular News Issue 34 – August 2014
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No i...
Cardiovascular News Issue 34 – August 2014 US Edition
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No i...
Cardiovascular News Issue 33 – May 2014
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year surv...
Cardiovascular News Issue 33 – May 2014 US Edition
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year surv...
Cardiovascular News Issue 32 – February 2014
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always...
Cardiovascular News Issue 32 – February 2014 US Edition
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always...
Cardiovascular News Issue 31 – October 2013
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypas...
Cardiovascular News Issue 31 – October 2013 US Edition
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypas...
Cardiovascular News issue 30 – August 2013
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised ...
Cardiovascular News issue 30 – August 2013 US edition
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised ...
Cardiovascular News issue 29 – May 2013
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcathete...
Cardiovascular News issue 29 – May 2013 US edition
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcathete...
Cardiovascular News Issue 27 – October 2012 US edition
Highlights:
-TRILOGY-ACS shows no advantage for prasugrel over clopidogrel
-Renal denervation ...
Cardiovascular News Issue 27 – October 2012
Highlights:
-TRILOGY-ACS shows no advantage for prasugrel over clopidogrel
-Renal denervation ...
Cardiovascular News Issue 26 – August 2012 US edition
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial pre...
Cardiovascular News Issue 26 – August 2012
Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial pre...
Cardiovascular News Issue 25 – May 2012
Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressu...
Cardiovascular News Issue 24 – February 2012 EU edition
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Trans...
Cardiovascular News Issue 24 – February 2012 US edition
Highlights:
-iFR vasodilator-free measure of stenosis severity comparable to FFR
-PARTNER A: Trans...
Cardiovascular News Issue 23 – November 2011
Highlights:
-Lower thrombosis risk with newer generation drug-eluting stents
-Intra-aortic balloon...
Cardiovascular News Issue 22 – August 2011
Highlights:
-FFR-CT technique can cut unnecessary coronary procedures
-"TAVI should be performed w...
Cardiovascular News Issue 21 – May 2011
Highlights:
-PARTNER find TAVI as good as surgery
-Absorb shows positive one-year safety and effic...
Cardiovascular News Issue 20 – Feb 2011
Highlights
- New absorbable stent era begins
- TAVI improves quality of life in inoperable patient...
Cardiovascular News Issue 19 – Sept 2010
Highlights
- ESC sees SHIFT in heart failure treatment
- FDA advisory committe recommends approval...
Cardiovascular News Issue 18 – Jul 2010
Highlights
- "Encouraging" TAVI results in high-risk patients
- Bioresorbable stent one step close...
Cardiovascular News Issue 17 – Apr 2010
Highlights
- NO ACCORDance on role of fibrates
- Cypher versus ENDEAVOR trial results cause stir
...
Cardiovascular News Issue 16 – Jan 2010
Highlights
- Controversy surrounds long-term lipid lowering therapy
- SPIRIT IV and COMPARE trials...
Cardiovascular News Issue 15 – Sep 2009
Highlights
- New drugs steal the spotlight at the ESC Congress
- SYNTAX at two years: Comparable o...
Cardiovascular News Issue 14 – Aug 2009
Highlights
- Drug-eluting stents "warranted" for infarction
- Syntax Score website: A tool for the...
Cardiovascular News Issue 13 – May 2009
Highlights
- Percutaneous mitral valve repair takes off
- Antiplatelet agent prasugrel receives CE...
Cardiovascular News Issue 12 – Jan 2009
Highlights
- JUPITER: reduced events in patients with low LDL cholesterol, raised CRP
- FFR-guided...
A quarter of an hour of exercise per day may reduce risk of death in older adults
A study, which was presented at EuroPRevent 2016 (14–15 June, Sophia Antipolis, France), indicates t...
Current issues in PCI: The latest data
The first edition of Current issues in PCI, which was published as a supplement alongside the Februa...
Current issues in PCI
The Stenting in Complex PCI meeting (2 December 2014, Milan, Italy) reviewed some of the most import...
DAPT and DES in coronary artery disease: Is it time to revisit the guidelines?
At a roundtable organised by Cardiovascular News, with an unrestricted educational grant from Medtro...
“Orsiro is a great example of some of the latest developments in DES technology”
Cardiovascular News interviews Francesco Bedogni from Sant’Ambrogio Hospital, Milan, Italy, on the d...
